Medicenna Therapeutics Corp. (MDNAF)

CIK 1807983 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Medicenna Therapeutics Corp..

Recent SEC filings

FiledFormAccession number
Jul 6, 2026D0001807983-26-000003
May 14, 2024D0001807983-24-000001
May 14, 202415-12G0001171843-24-002865
May 13, 2024EFFECT9999999995-24-001503
May 13, 20246-K0001171843-24-002798
May 10, 2024POS AM0001171843-24-002763
May 10, 2024SC 13G0001104659-24-060023
Apr 30, 20246-K0001104659-24-054880
Apr 26, 20246-K0001104659-24-052859
Apr 25, 20246-K0001171843-24-002233
Apr 22, 2024AW0001171843-24-002129
Apr 16, 2024F-3/A0001171843-24-002033
Apr 16, 2024F-10POS0001171843-24-002032
Apr 16, 2024S-8 POS0001171843-24-002034
Apr 10, 20246-K0001171843-24-001936
Apr 9, 20246-K0001171843-24-001924
Apr 4, 20246-K0001171843-24-001834
Mar 6, 20246-K0001171843-24-001208
Feb 21, 2024SC 13G/A0001104659-24-026196
Feb 14, 20246-K0001171843-24-000779
Feb 13, 20246-K0001171843-24-000739
Feb 7, 2024SC 13G/A0001493152-24-005332
Jan 24, 20246-K0001104659-24-006239
Jan 16, 20246-K0001171843-24-000246
Jan 9, 20246-K0001171843-24-000151